All Posts Tagged With: "BSX"
(STJ) St. Jude Medical Build on Alliance with Abbott Laboratories
St. Jude Medical Inc. (STJ) recently disclosed its decision to build on its mutual agreement with Abbott Laboratories (ABT) by revealing...
(STJ) St. Jude Beats The Street – Raises Guidance
St. Jude Medical, Inc. (STJ), a large-cap medical devices and technology development company, reported first quarter fiscal 2012 adjusted earnings of 86 cents beating the Zacks Consensus Estimate of 83 cents...
(XOM) Share Buybacks: A Buy Signal You Can’t Ignore
Share buybacks increased by 46% in 2011. Has there ever been a more...19Mar2012 | InvestmentU | 0 comments | Continued
(MDT) MedTech Industry Stock Outlook – March 2012 – Zacks Analyst Interviews
Last year proved to be challenging for medical technology (“MedTech”) stocks given the exigent economic conditions and the precarious healthcare environment. The performance of incumbent players was hamstrung by several macro issues, including sustained price and procedure...
(MDT) MedTech Industry Stock Outlook – March 2012 – Industry Outlook
Last year proved to be challenging for medical technology (“MedTech”) stocks given the exigent economic conditions and the precarious healthcare environment. The performance of incumbent players was hamstrung by several macro issues, including sustained price and procedure...
(GB) Greatbatch Buying NeuroNexus
Medical technology company Greatbatch (GB) is acquiring Michigan-based implantable medical device design firm NeuroNexus Technologies for roughly $12 million. The deal includes assumption of debt and future...
(STJ) St. Jude Medical Fourth Quarter 2011 Earnings Scorecard
Medical devices major St. Jude Medical’s (STJ) fourth-quarter 2011 adjusted earnings per share of 86 cents beat the Zacks Consensus Estimate by a couple of cents and exceeded the year-ago earnings of 75...
(STJ) New Year Bets from MedTech
Picking the right stock is never easy, especially in a difficult and volatile market. There are thousands of stocks to choose from and many investors eventually end up boiling the ocean.
The U.S. economy continues to be cramped by a spate of headwinds including a still...
(STJ) Christmas Gift for the Ailing Heart
Wilson Greatbatch, the self-professed “humble tinkerer” and a trailblazer in medical technology, invented the first implantable cardiac pacemaker in 1958 which kept the rhythm of millions of heartbeats and preserved countless lives across the planet.
A couple...
(BSX) Boston Scientific Corporation Grows US Cardiac Rhythm Management Portfolio
Boston Scientific Corporation’s (BSX) Cardiac Rhythm Management (CRM) should record higher sales with the US Food and Drug Administration (FDA) approving Incepta, Energen and Punctua cardiac resynchronization...
(MDT) Medtronic 2012 Second Quarter Earnings Scorecard
The announcement of Medtronic’s (MDT) second quarter fiscal 2012 results, as on November 22, 2011, has led analysts to revise their estimates lower for the third quarter although the situation improves...
(MDT) Medical Technology Industry Stock Outlook – November 2011 – Industry Outlook
The performance of incumbent players in the MedTech industry continued to be hamstrung by a spate of macro issues (including sustained price and procedure volume pressures) in the September quarter. The prevailing macroeconomic factors, pricing headwinds, austerity measures,...
(EW) Edwards Lifesciences Earns FDA OK on Trial Enrollment
Recently, Edwards Lifesciences Corporation (EW) received conditional approval from the US Food and Drug Administration for enrollment of a certain group of patients in the PARTNER II trial. The trial is studying...
(SYK) Stryker Third Quarter 2011 Earnings Scorecard
Orthopedic devices giant Stryker Corporation’s (SYK) third-quarter 2011 adjusted (excluding acquisition charges) earnings per share of 91 cents topped the Zacks Consensus Estimate of 89 cents and the year-ago...
(GB) Greatbatch Analyst Raises Shares to Outperform
We upgrade our recommendation on Greatbatch (GB) to Outperform following its impressive third-quarter 2011 results. Adjusted earnings of 41 cents for the quarter outstripped the Zacks Consensus Estimate of...
(GB) Greatbatch Third Quarter 2011 Earnings Helped By Medical Business
Greatbatch’s (GB) third-quarter fiscal 2011 adjusted (excluding one-time items) earnings per share of 41 cents outpaced both the Zacks Consensus Estimate and the year-ago adjusted earnings of 34 cents.
Profit...
(EW) Edwards Lifesciences 2011 Fourth Quarter Earnings Scorecard
The announcement of Edwards Lifesciences’ (EW) third quarter fiscal 2011 results as on October 19, 2011, has led analysts to revise their estimates lower for the fourth quarter and fiscal 2011.
Third...
(EW) Edwards Lifesciences Corporation Earnings Preview
Edwards Lifesciences Corporation (EW) is scheduled to release its third quarter fiscal 2011 results on Wednesday, October 19, 2011 after the market closes.
The company is expected to earn 39 cents per...
(AAPL) A Busy Week Ahead – Earnings Preview
Earnings Preview 10/14/11
While the earnings season kicked off this past week, only 38 firms reported. The game really gets under way next week, when we will get reports from 336 firms, including 99 members of the S&P 500.
Thus, by the end of the week we...
(EW) Edwards Lifesciences Announces Share Buyback
Edwards Lifesciences Corporation (EW) recently announced a new share repurchase program worth $500 million. At the end of the second quarter of fiscal 2011, the company was left with $240 million of authorization....
(EW) Edwards Lifesciences Sapien Under Centers for Medicare & Medicaid Services NCA
Edwards Lifesciences (EW) received a major setback as the Centers for Medicare & Medicaid Services (CMS) decided to initiate a National Coverage Analysis (NCA) of transcatheter aortic valve replacement...
(BSX) Boston Scientific Launches Coyote Balloon Catheter
Boston Scientific Corporation (BSX) strengthened its Peripheral Interventions portfolio with the launch of Coyote Balloon catheter (0.014 inch) to treat patients undergoing peripheral angioplasty procedures...
(MDT) Medtronic Grows Spinal Portfolio
Leading medical devices player, Medtronic’s (MDT) TSRH Spinal System has received 510 (k) clearance from the US Food and Drug Administration (FDA) to treat adolescent idiopathic scoliosis (AIS) with pedicle...
(MDT) Medical Devices Stock Outlook – Sept. 2011 – Industry Outlook
June quarter results mostly mirror the preceding quarter as a host of macro headwinds (including price and procedure volume pressures) continued to haunt the MedTech industry and weighed on the performance of the incumbent players. Although a number of these issues are expected...
(GB) Greatbatch Analyst Reaffirms Shares at Neutral
We reiterate our Neutral recommendation for Greatbatch Inc. (GB). Second-quarter fiscal 2011 earnings per share of 43 cents met the Zacks Consensus Estimate. Revenues rose 4% year over year to $146.5 million,...
(BSX) Boston Scientific – Bull of the Day
Boston Scientific (BSX) reported second-quarter adjusted EPS of $0.12 on revenues which increased 2.4% to $1.975 billion. Both numbers beat the Zacks Consensus Estimates. Following the launch of its Ion stent...
(SYK) Stryker Meets The Strret But Costs Hurt
Orthopedic devices major Stryker Corporation (SYK) posted second-quarter fiscal 2011 adjusted earnings per share of 90 cents, meeting the Zacks Consensus Estimate while transcending the year-agoearnings of...
(BSX) Company News for July 29, 2011 – Corporate Summary
• Credit Suisse (NYSE:CS) announced that it will cut 2,000 jobs worldwide after the banking giant was hit by a decline in second quarter profits and an appreciating Swiss franc
• A report from Sky News...
(AAPL) 2011 Second Quarter Earnings Preview – Detailed
Earnings Preview 7/15/11
Second quarter earnings season is now under way, but things really start to move into high gear next week. There will be 348 firms reporting, and 108 of those are...
(SYK) Stryker Wraps Up Memometal Buy
Orthopedic devices giant Stryker Corp (SYK) has completed the acquisition of France-based privately-held extremity devices maker Memometal Technologies S.A. for $150 million in cash. The deal, which was announced...